Patents by Inventor Mario Campone

Mario Campone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for in vitro diagnosing and prognosing of triple negative breast cancer recurrence
    Patent number: 10859577
    Abstract: The present invention is in the technical field of breast cancer management, and more particularly relates to the diagnosis and/or prognosing of triple-negative breast cancer (TNBC). The invention is more particularly based on the finding that specific biomarkers are abberantly expressed in patients suffering from a triple-negative breast cancer recurrence, and are highly related to the aggressiveness of this disease, and thus to survival of said patient.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: December 8, 2020
    Assignees: Institut de Cancerologie de L'Ouest, Universite D'Angers, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Catherine Guette, Mario Campone, Olivier Coqueret, Benjamin Barre
  • Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer
    Patent number: 10436787
    Abstract: The present invention is in the technical field of breast cancer management, and more particularly relates to the diagnosis of breast cancer. The invention is more particularly based on the finding that specific biomarkers (olfactomedin-4, neudesin and desmoplakin) are abberantly expressed in the blood of breast cancer patients.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: October 8, 2019
    Assignees: Institut de Cancerologie de L'Ouest, Universite D'Angers, Institut National de la Sante de la Recherche Medicale (INSERM)
    Inventors: Catherine Guette, Pedro Raro, Olivier Coqueret, Benjamin Barre, Mario Campone
  • Method for In Vitro Diagnosing and Prognosing of Triple Negative Breast Cancer Recurrence
    Publication number: 20160291021
    Abstract: The present invention is in the technical field of breast cancer management, and more particularly relates to the diagnosis and/or prognosing of triple-negative breast cancer (TNBC). The invention is more particularly based on the finding that specific biomarkers are abberantly expressed in patients suffering from a triple-negative breast cancer recurrence, and are highly related to the aggressiveness of this disease, and thus to survival of said patient.
    Type: Application
    Filed: November 24, 2014
    Publication date: October 6, 2016
    Inventors: Catherine Guette, Mario Campone, Olivier Coqueret, Benjamin Barre
  • Olfactomedin-4, Neudesin and Desmoplakin as Biomarkers of Breast Cancer
    Publication number: 20160291022
    Abstract: The present invention is in the technical field of breast cancer management, and more particularly relates to the diagnosis of breast cancer. The invention is more particularly based on the finding that specific biomarkers (olfactomedin-4, neudesin and desmoplakin) are abberantly expressed in the blood of breast cancer patients.
    Type: Application
    Filed: November 24, 2014
    Publication date: October 6, 2016
    Inventors: Catherine Guette, Pedro Raro, Olivier Coqueret, Benjamin Barre, Mario Campone